A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control ...

Nov 2026 - ASX-listed radiopharmaceutical company's Cu-64 SAR-bisPSMA receives expedited review status for recurrent prostate cancer detection.

Prostate cancer rates are on the rise. More than 300,000 cases are diagnosed every year, affecting 1 in 8 men. Among African ...

Tonight at 7:30, Penn State Health and abc27 will host a special program: "Prostate Cancer: Where Breakthroughs Change Lives". Viewers will discover breakthroughs in prostate cancer treatment, ...

About one in eight American men will be diagnosed with prostate cancer during their lifetime. It is the second-deadliest cancer for American men, claiming tens of thousands of lives every year. Today, ...

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- The Davos of Healthcare™ Summit, on September 14 in New York City, will proudly host the global launch of 5Q Spectra's Prostate Dx™, known as the "PSB" Blood ...

Cancer has been called the emperor of all maladies. It is what we quietly fear, what we cannot always prevent and what can suddenly transform not only the life of the person diagnosed, but the lives ...

Frederick Health says a breakthrough cancer therapy has landed in western Maryland, delivering radiation straight to tumor ...

Learn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.

Researchers have discovered the genetic blueprints of 18 new bacterial species in prostate cancer patients, in a breakthrough ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company targeting drug resistance in cancer, announces that it has been named a winner of the 2026 Biotech Breakthrough ...